Bridgefront Capital, LLC - GOSSAMER BIO INC ownership

GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 125 filers reported holding GOSSAMER BIO INC in Q4 2020. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bridgefront Capital, LLC ownership history of GOSSAMER BIO INC
ValueSharesWeighting
Q1 2022$111,000
-11.9%
12,750
-6.7%
0.14%
+248.7%
Q1 2021$126,000
-30.8%
13,672
-27.2%
0.04%
-37.1%
Q4 2020$182,00018,7880.06%
Other shareholders
GOSSAMER BIO INC shareholders Q4 2020
NameSharesValueWeighting ↓
Omega Fund Management, LLC 3,320,608$41,740,0004.68%
Octagon Capital Advisors LP 1,513,138$19,020,0004.68%
Ally Bridge Group (NY) LLC 1,175,000$14,770,0004.34%
Parkman Healthcare Partners LLC 786,870$9,891,0002.50%
Palo Alto Investors LP 1,772,950$22,286,0001.34%
HHLR ADVISORS, LTD. 7,420,974$93,282,0001.22%
Ikarian Capital, LLC 1,351,933$16,995,0001.20%
Boxer Capital, LLC 2,462,358$30,952,0001.08%
ACUTA CAPITAL PARTNERS, LLC 215,000$2,703,0000.95%
EMERALD ADVISERS, LLC 1,516,003$19,056,0000.69%
View complete list of GOSSAMER BIO INC shareholders